戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 activation with hAmylin, Abeta1-42, or their co-application.
2 ssed below the control level during repeated co-applications.
3 udy investigated the synergy of biochar-lime co-application (BL) in remediating acidic soils and sust
4        Interestingly, the PNU-120596 agonist co-application data revealed that for wild-type alpha7 n
5 ddition, the polarity of the response to the co-application depends on the membrane potential of BF n
6 op plants, the impacts of their simultaneous co-application has not been well documented.
7 ippocampus and antagonized NIC response upon co-application implying partial agonist properties.
8 tes of modification were accelerated by GABA co-application, indicating that channel activation incre
9            These results demonstrate that BL co-application is a promising strategy for managing acid
10              At -40 mV the net effect of the co-application is inhibition by dynorphin-A, whereas at
11  BF neurons; at -40 mV the net effect of the co-application is inhibition by dynorphin-A, whereas at
12                                              Co-application of 0.01 to 67 mM BDM increased IGly decay
13  these currents significantly reduced by the co-application of 100 microM AMPA.
14 ed cells by recording the current induced by co-application of 30 mM potassium.
15 onal cell layers, which could be reversed by co-application of 5 mM lactate.
16                  This was partly reversed by co-application of 5 mM lactate.
17                          Responses caused by co-application of 5-HT (300 microM), acting at 5-HT3 rec
18                                              Co-application of 50 microM forskolin made the glycine-i
19 the LTD induction by serotonin + tetani, and co-application of a group I mGluR agonist and serotonin,
20 permeability increases could be prevented by co-application of a mixture of the antioxidants superoxi
21                      Peak currents caused by co-application of ACh (1 mM) and ATP (300 microM) were 7
22             In outside-out membrane patches, co-application of ACh (4 microM) and VIP (4 nM) decrease
23          Reversal potentials measured during co-application of ACh and ATP did not differ from those
24                                              Co-application of alphabeta-MeATP (300 microM) with ATP
25                                              Co-application of amitriptyline or bupivacaine, which ta
26                                    Moreover, co-application of an anti-ASC antibody blocked the incre
27                                              Co-application of AP-5 and CNQX completely eliminated th
28 uced phase-shifts at ZT 10 are unaffected by co-application of baclofen.
29                                          The co-application of BAPTA (10 mM) with adenophostin blocke
30 17 activity can neither be accomplished with co-application of both ligand classes, nor with exogenou
31                                  Conversely, co-application of bradykinin or the P2Y-receptor agonist
32 rents, which were significantly increased by co-application of colominic acid.
33                                              Co-application of compost to provide organics may serve
34 , as a proxy for true intensity, through the co-application of cone calorimetry and Raman spectroscop
35                                              Co-application of diC8-PIP(2) and Ca(2+) prevents rundow
36                We have previously shown that co-application of dopamine or the D2-like agonist quinpi
37 dynorphin-A and to orexin-A desensitize, but co-application of dynorphin-A and orexin-A produces a su
38 in-A desensitize over multiple applications, co-application of dynorphin-A and orexin-A produces a su
39 ic contaminants and confirms the benefits of co-application of ferrate(VI) and PAA for alkaline waste
40                                 Intraplantar co-application of flagellin and QX-314 (flagellin/QX-314
41  In vivo electrophysiology demonstrated that co-application of flagellin/QX-314 selectively suppresse
42                                              Co-application of foliar Se with an N carrier doubled th
43  the prominent membrane current rebound when co-application of GABA and CTZ was terminated suggests t
44  by a saturating concentration of GABA or by co-application of GABA and pentobarbital were recorded u
45                   Currents were abolished by co-application of GABA with the GABA(A) receptor antagon
46 id ((RS)-CPP), and completely blocked by the co-application of GYKI 52466, 6-cyano-7-nitroquinoxaline
47                                              Co-application of HpSlyD and FK506 led to significant re
48 trifugal neurons, the eEPSCs were blocked by co-application of KYNA and MCM, whereas in the medulla n
49                                              Co-application of leptin (5 mug) and TRH (0.1 microg) to
50                                              Co-application of LTB4 and cholane steroid did not furth
51                                              Co-application of LTB4 with LTA4, LTC4, LTD4, or LTE4 su
52                                              Co-application of NE with ATP to resting microglia block
53 centrations of glycine, either alone or with co-application of NMDA, through a microdialysis probe im
54                                              Co-application of nociceptin and DADLE to neurons that w
55                                              Co-application of NT and AID peptide negated inhibitory
56 urating concentrations of agonists where the co-application of one agonist resulted in both facilitat
57          The effects of cPKA were blocked by co-application of PKA inhibitor (6-22) amide (PKI).
58 When treatment was done at 53 degrees C, the co-application of potassium sorbate with thiabendazole r
59                                We found that co-application of retigabine strongly decreased the nico
60 +)DPAT, and this inhibition was decreased by co-application of tetrodotoxin.
61 amatergic and cholinergic receptors, because co-application of the glutamate antagonist kynurenic aci
62 on caused by DHPG (3 microM) was reversed by co-application of the mGlu receptor antagonist (+)-alpha
63  similar off-response is also observed after co-application of the negative modulator DHEAS and the p
64 pha4beta2-nAChR is significantly enhanced by co-application of the proinflammatory cytokine, tumor ne
65 tatory action of 8-OH-DPAT was attenuated by co-application of the selective 5-HT(1A) receptor antago
66  antiallodynic activity of 8b was removed by co-application of the sigma(1) agonist PRE-084, proving
67 ed Calvin cycle downregulation by FB1, while co-application of the toxin with PSK increased Calvin cy
68 g fruit storage and were not affected by the co-application of thiabendazole.
69 mplitude), but these were not potentiated by co-application of up to 100 mM glycine.
70                                          The co-application of ZD 7288 and Ba2+ revealed a depolarizi
71 d the epidermal hyperplasia were reversed by co-applications of palmitic acid (but not linoleic acid)
72                  In this study, we evaluated co-applications of the entomopathogenic fungi (EPF) Beau
73 ier homeostasis could be reversed by topical co-applications of the nonessential fatty acid, and of p
74 ays in barrier recovery can be overridden by co-applications of topical ceramide, demonstrating that
75 ent effects that were unaltered by etomidate co-application, precluding a direct estimate of intermol
76 enuated the PM-induced inward current during co-application, providing further evidence that PDM func
77                    Finally, flagellin/QX-314 co-application suppressed sodium currents in large-diame
78 0 microM carbachol was enhanced by the first co-application with 10 or 100 microM neostigmine, and th
79 ound anesthetic was inferred when anesthetic co-application with alkyl-MTS reagent blocked the develo
80 ) to wheat can be made more efficient by its co-application with macronutrient carriers, either to th
81 it able to potentiate responses during brief co-application with the agonist.
82 ted but did not eliminate protection, whilst co-application with the NMDA receptor blocker MK-801 inc
83                                              Co-application with V(i) enhanced the tip labeling, whic
84                                       Ligand co-applications with the positive allosteric modulator P